ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 626540 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 626540; 2) Community: the network communities that were significantly associated with the response to NSC 626540; 3) Molecule: the relationships between components within communities and NSC 626540; 4) MDR: the compounds that were significantly associated with the NSC 626540.

NSC Compound Enrichment Correlation
NSC 683558 Camptothecin Derivative 0.0459335986102865 0.47865306
NSC 683608 Null 0.0459335986102865 0.11886046
NSC 700893 5H-Furo[3',2':4,5]furo[3,2-b]xanthen-5-one, 3a,12a-dihydro-3a,4,6-trihydroxy-9-(3-hydroxy-3-methylbutyl)-, (3aR,12aR)- (9CI) 0.0459335986102865 -0.14505991
NSC 713197 Benzo[g]quinoxaline-2,3-dicarboxylic acid, 5,10-dihydro-5,10-dioxo-, diethyl ester 0.0459335986102865 -0.036347638
NSC 740618 (Z)-1-(2-chloro-5-(trifluoromethyl)phenyl)-4-(2-hydroxybenzylidene)-2-phenyl-1H-imidazol-5(4H)-one 0.0459335986102865 0.0092940116
NSC 144173 Quinoxaline, 2,3-bis(iodomethyl)-6-methoxy- 0.0459335986102872 0.56487716
NSC 200692 Aspiculamycin hydrochloride 0.0459335986102872 -0.18576465
NSC 294600 MELAMPODININ 0.0459335986102872 0.51801395
NSC 354258 Null 0.0459335986102872 0.44341264
NSC 625498 4-Morpholinecarbodithioic acid, antimony complex 0.0459335986102872 0.48528024
Total:149  Current:138    [First] [Prev] [Next] [Last]